Overview

BEACON: Phase 3 Study of bardoxolone methyl in Patients with Chronic Kidney Disease and Type 2 Diabetes.

For more information about clinical trials:

www.clinicaltrials.gov
www.ciscrp.org
www.centerwatch.com